
Spectrum Pharmaceuticals SPPI
Spectrum Pharmaceuticals DSO | SPPI
DSO Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 235 | - | - | - | 104 | 102 | 87.4 | 135 | 118 | 180 | 103 | 73.5 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 235 | 73.5 | 126 |
DSO Vierteljährlich Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 134 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 92.1 | 103 | 115 | 98.2 | 112 | 100 | 108 | 124 | 75 | 116 | 79.1 | 64.3 | 103 | 144 | 143 | 166 | 116 | 111 | 108 | 118 | 118 | 118 | 130 | 205 | 119 | 116 | 93.1 | 81.6 | 85.7 | 84.3 | 98.7 | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 205 | 64.3 | 112 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Savara
SVRA
|
2.41 K | $ 4.28 | -17.95 % | $ 952 M | ||
|
Teligent, Inc.
TLGT
|
90.7 | - | -13.85 % | $ 16.1 M | ||
|
Viela Bio, Inc.
VIE
|
169 | - | - | $ 2.91 B | ||
|
Sutro Biopharma
STRO
|
22.4 | $ 8.6 | -1.38 % | $ 73.1 M | ||
|
Tarsus Pharmaceuticals
TARS
|
53.3 | $ 72.94 | -6.09 % | $ 3.05 B | ||
|
Supernus Pharmaceuticals
SUPN
|
83.7 | $ 36.28 | 1.88 % | $ 2.05 B | ||
|
TG Therapeutics
TGTX
|
129 | $ 63.39 | -2.3 % | $ 9.15 B | ||
|
Aphria Inc.
APHA
|
55.2 | - | -0.45 % | $ 4.87 B | ||
|
Chiasma, Inc.
CHMA
|
178 | - | -6.00 % | $ 238 M | ||
|
vTv Therapeutics
VTVT
|
29.4 | $ 16.0 | -2.2 % | $ 64.2 M | ||
|
Adamas Pharmaceuticals, Inc.
ADMS
|
45.6 | - | - | $ 376 M | ||
|
Xenon Pharmaceuticals
XENE
|
35.7 | $ 36.89 | -1.78 % | $ 2.92 B | ||
|
Xeris Pharmaceuticals
XERS
|
57.2 | $ 16.95 | 2.02 % | $ 2.72 B | ||
|
X4 Pharmaceuticals
XFOR
|
46.1 | $ 3.01 | 1.69 % | $ 127 M | ||
|
Cerecor Inc.
CERC
|
239 | - | -1.68 % | $ 283 M | ||
|
Auris Medical Holding Ltd.
EARS
|
147 | - | -1.77 % | $ 39.2 M | ||
|
Dicerna Pharmaceuticals, Inc.
DRNA
|
80.1 | - | 0.34 % | $ 2.98 B | ||
|
ERYTECH Pharma S.A.
ERYP
|
52.8 | - | 1.3 % | $ 27.7 M | ||
|
GW Pharmaceuticals plc
GWPH
|
49.3 | - | - | $ 6.81 B | ||
|
22nd Century Group
XXII
|
54.9 | $ 0.32 | -19.83 % | $ 58.9 K | ||
|
Kadmon Holdings, Inc.
KDMN
|
30.6 | - | - | $ 1.7 B | ||
|
Liminal BioSciences
LMNL
|
429 | - | - | $ 256 M | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
139 | $ 2.33 | -7.25 % | $ 19.8 M | ||
|
Zai Lab Limited
ZLAB
|
75.9 | $ 21.01 | -4.16 % | $ 23 B | ||
|
Neos Therapeutics, Inc.
NEOS
|
150 | - | -2.54 % | $ 57.2 M | ||
|
Zentalis Pharmaceuticals
ZNTL
|
22.6 | $ 1.37 | 0.74 % | $ 98.5 M | ||
|
Zoetis
ZTS
|
56 | $ 78.81 | -2.47 % | $ 34.9 B | ||
|
Osmotica Pharmaceuticals plc
OSMT
|
54.2 | - | -10.74 % | $ 89.9 M | ||
|
Pandion Therapeutics, Inc.
PAND
|
0.0395 | - | - | $ 1.77 B | ||
|
Xenetic Biosciences
XBIO
|
365 | $ 1.47 | -4.55 % | $ 2.5 M | ||
|
Translate Bio, Inc.
TBIO
|
69.9 | - | - | $ 2.81 B | ||
|
Trillium Therapeutics Inc.
TRIL
|
2.34 K | - | - | $ 1.94 B | ||
|
Acceleron Pharma Inc.
XLRN
|
42.2 | - | - | $ 10.9 B | ||
|
Zogenix, Inc.
ZGNX
|
102 | - | -4.97 % | $ 664 M | ||
|
ZIOPHARM Oncology, Inc.
ZIOP
|
4.66 K | - | -7.58 % | $ 264 M | ||
|
Vericel Corporation
VCEL
|
96.5 | $ 57.41 | -1.46 % | $ 2.89 B | ||
|
Vir Biotechnology
VIR
|
9.84 | $ 8.37 | -5.64 % | $ 1.16 B | ||
|
Veracyte
VCYT
|
32.2 | $ 25.08 | 0.16 % | $ 1.97 B |